A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents. [electronic resource]
Producer: 20130911Description: 364-71 p. digitalISSN:- 1532-0987
- Adolescent
- Antigens, Bacterial -- genetics
- Australia
- Bacterial Proteins -- genetics
- Blood Bactericidal Activity
- Child
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Female
- Humans
- Male
- Meningococcal Infections -- immunology
- Meningococcal Vaccines -- administration & dosage
- Neisseria meningitidis, Serogroup B -- genetics
- Recombinant Proteins -- genetics
- Single-Blind Method
- Vaccines, Synthetic -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.